You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

 

2066 Results
Drug
Other Name(s): Cytosar®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jul 2025
Regimen
Cancer Type:
Hematologic, 
Leukemia - Acute Myeloid (AML)
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Funding:
Exceptional Access Program
    midostaurin - First-line treatment of adult patients diagnosed with FLT3-mutated acute myeloid leukemia, in combination with specific standard induction followed by consolidation chemotherapy, according to clinical criteria
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
cytarabine,
midostaurin
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jul 2025
Document
New
Jul 2025
Document
New
Jul 2025
Document
New
Jul 2025
Document
New
Jul 2025
Document
New
Jul 2025
Document
New
Jul 2025
Guidelines and Advice
Status: Current
ID: GL MOTAC-4
Version: 3
Dec 1969
Statistical Reports
Dec 1969
Statistical Reports
Jan 2018
Statistical Reports
Dec 1969

Pages